SomnoMed Limited
SOMNF
$0.4361
-$0.0487-10.05%
OTC PK
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | 43.74% | 3.24% | -49.01% | -66.86% | -95.92% |
Total Depreciation and Amortization | 12.71% | 19.16% | 24.35% | 18.08% | 12.52% |
Total Amortization of Deferred Charges | 4.80% | 4.80% | 4.80% | 48.39% | 175.77% |
Total Other Non-Cash Items | -4.19% | -37.79% | -89.31% | 403.08% | 198.49% |
Change in Net Operating Assets | 66.74% | 66.74% | 66.74% | -256.61% | -254.93% |
Cash from Operations | 146.41% | 56.37% | -59.14% | -108.80% | -248.18% |
Capital Expenditure | 18.07% | 42.16% | 56.89% | 43.95% | 26.55% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -10.69% | -15.48% | -17.78% | 41.42% | 66.11% |
Cash from Investing | 0.94% | 10.70% | 18.76% | 42.27% | 56.69% |
Total Debt Issued | -- | -- | -- | -99.20% | -98.57% |
Total Debt Repaid | -69.16% | -94.78% | -119.70% | -66.36% | -7.44% |
Issuance of Common Stock | 61.28% | 322.57% | -- | 26,325,500.00% | 7,286,600.00% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | 11.68% | 84.14% | 147.31% | 21.16% | -49.13% |
Foreign Exchange rate Adjustments | 224.36% | 124.73% | -30,017.65% | -50.40% | 25.55% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 235.83% | 224.08% | 211.09% | 102.05% | -389.56% |